APO Research
Talk to an analyst

APO RESEARCH · REPORT

Percutaneous Coronary Intervention (PCI) Treatment Instruments

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Analysis and Forecast 2026-2032

25 December 2025215 pages

Choose your research edition.

Industry ResearchPercutaneous Coronary Intervention (PCI) Treatment Instruments Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Percutaneous Coronary Intervention (PCI) Treatment Instruments market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Percutaneous Coronary Intervention (PCI) Treatment Instruments is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Percutaneous Coronary Intervention (PCI) Treatment Instruments include Medtronic, OrbusNeich Medical Company, MicroPort Scientific Corporation, Suzhou Innomed Medical Device, Shunmei Medical, Shanghai INT Medical Instruments, Lepu Medical Technology, APT Medical and BrosMed Medical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Percutaneous Coronary Intervention (PCI) Treatment Instruments, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Percutaneous Coronary Intervention (PCI) Treatment Instruments, also provides the revenue of main regions and countries. Of the upcoming market potential for Percutaneous Coronary Intervention (PCI) Treatment Instruments, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Percutaneous Coronary Intervention (PCI) Treatment Instruments revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Percutaneous Coronary Intervention (PCI) Treatment Instruments revenue, projected growth trends, production technology, application and end-user industry.

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Company

Medtronic

OrbusNeich Medical Company

MicroPort Scientific Corporation

Suzhou Innomed Medical Device

Shunmei Medical

Shanghai INT Medical Instruments

Lepu Medical Technology

APT Medical

BrosMed Medical

Terumo Corporation

QualiMe

Merit Medical

Curatia Medical

Cordis

Cardionovum

Boston Scientific

ASAHI INTECC

Abbott

Zhejiang Barty Medical Technology

Shenzhen MicroApproach Medical Technology

Beijing Demax Medical Technology

JW Medical Systems

SINOMED

Kinhely Bio-Tech

Shandong Huaan Biotechnology

Blue Sail Medical

Shanghai Bio-heart Biological Technology

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Type

Coronary Pathway Assistive Instruments

Interventional Treatment Instruments

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Application

Hospital

Clinic

Others

Percutaneous Coronary Intervention (PCI) Treatment Instruments Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Coronary Intervention (PCI) Treatment Instruments market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Coronary Intervention (PCI) Treatment Instruments and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Coronary Intervention (PCI) Treatment Instruments.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Percutaneous Coronary Intervention (PCI) Treatment Instruments in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Percutaneous Coronary Intervention (PCI) Treatment Instruments company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Percutaneous Coronary Intervention (PCI) Treatment Instruments revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Coronary Pathway Assistive Instruments Major Player Table 3. Interventional Treatment Instruments Major Player Table 4. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends Table 9. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Drivers Table 10. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Opportunities and Challenges Table 11. Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Restraints Table 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region (2021-2026) Table 15. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region (2027-2032) Table 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Players (2021-2026) Table 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Key Players Headquarters & Area Served Table 21. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players, Product Type & Application Table 22. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2021-2026) Table 29. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2027-2032) Table 30. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2021-2026) Table 34. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2027-2032) Table 35. Medtronic Company Information Table 36. Medtronic Business Overview Table 37. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 39. Medtronic Recent Development Table 40. OrbusNeich Medical Company Company Information Table 41. OrbusNeich Medical Company Business Overview Table 42. OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 44. OrbusNeich Medical Company Recent Development Table 45. MicroPort Scientific Corporation Company Information Table 46. MicroPort Scientific Corporation Business Overview Table 47. MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 49. MicroPort Scientific Corporation Recent Development Table 50. Suzhou Innomed Medical Device Company Information Table 51. Suzhou Innomed Medical Device Business Overview Table 52. Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 54. Suzhou Innomed Medical Device Recent Development Table 55. Shunmei Medical Company Information Table 56. Shunmei Medical Business Overview Table 57. Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 59. Shunmei Medical Recent Development Table 60. Shanghai INT Medical Instruments Company Information Table 61. Shanghai INT Medical Instruments Business Overview Table 62. Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 64. Shanghai INT Medical Instruments Recent Development Table 65. Lepu Medical Technology Company Information Table 66. Lepu Medical Technology Business Overview Table 67. Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 69. Lepu Medical Technology Recent Development Table 70. APT Medical Company Information Table 71. APT Medical Business Overview Table 72. APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 74. APT Medical Recent Development Table 75. BrosMed Medical Company Information Table 76. BrosMed Medical Business Overview Table 77. BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 79. BrosMed Medical Recent Development Table 80. Terumo Corporation Company Information Table 81. Terumo Corporation Business Overview Table 82. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 84. Terumo Corporation Recent Development Table 85. QualiMe Company Information Table 86. QualiMe Business Overview Table 87. QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 89. QualiMe Recent Development Table 90. Merit Medical Company Information Table 91. Merit Medical Business Overview Table 92. Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 94. Merit Medical Recent Development Table 95. Curatia Medical Company Information Table 96. Curatia Medical Business Overview Table 97. Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 99. Curatia Medical Recent Development Table 100. Cordis Company Information Table 101. Cordis Business Overview Table 102. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 104. Cordis Recent Development Table 105. Cardionovum Company Information Table 106. Cardionovum Business Overview Table 107. Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 109. Cardionovum Recent Development Table 110. Boston Scientific Company Information Table 111. Boston Scientific Business Overview Table 112. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 114. Boston Scientific Recent Development Table 115. ASAHI INTECC Company Information Table 116. ASAHI INTECC Business Overview Table 117. ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 119. ASAHI INTECC Recent Development Table 120. Abbott Company Information Table 121. Abbott Business Overview Table 122. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 124. Abbott Recent Development Table 125. Zhejiang Barty Medical Technology Company Information Table 126. Zhejiang Barty Medical Technology Business Overview Table 127. Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 129. Zhejiang Barty Medical Technology Recent Development Table 130. Shenzhen MicroApproach Medical Technology Company Information Table 131. Shenzhen MicroApproach Medical Technology Business Overview Table 132. Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 134. Shenzhen MicroApproach Medical Technology Recent Development Table 135. Beijing Demax Medical Technology Company Information Table 136. Beijing Demax Medical Technology Business Overview Table 137. Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 139. Beijing Demax Medical Technology Recent Development Table 140. JW Medical Systems Company Information Table 141. JW Medical Systems Business Overview Table 142. JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 144. JW Medical Systems Recent Development Table 145. SINOMED Company Information Table 146. SINOMED Business Overview Table 147. SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 149. SINOMED Recent Development Table 150. Kinhely Bio-Tech Company Information Table 151. Kinhely Bio-Tech Business Overview Table 152. Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 154. Kinhely Bio-Tech Recent Development Table 155. Shandong Huaan Biotechnology Company Information Table 156. Shandong Huaan Biotechnology Business Overview Table 157. Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 158. Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 159. Shandong Huaan Biotechnology Recent Development Table 160. Blue Sail Medical Company Information Table 161. Blue Sail Medical Business Overview Table 162. Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 163. Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 164. Blue Sail Medical Recent Development Table 165. Shanghai Bio-heart Biological Technology Company Information Table 166. Shanghai Bio-heart Biological Technology Business Overview Table 167. Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 168. Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio Table 169. Shanghai Bio-heart Biological Technology Recent Development Table 170. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 171. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 172. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 173. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 174. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026) & (US$ Million) Table 176. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (US$ Million) & (2027-2032) Table 177. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 178. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 179. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 180. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 181. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 182. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026) & (US$ Million) Table 183. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (US$ Million) & (2027-2032) Table 184. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 185. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 186. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 187. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 188. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 191. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Region (US$ Million) & (2021-2026) Table 194. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Region (US$ Million) & (2027-2032) Table 195. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026) & (US$ Million) Table 196. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032) & (US$ Million) Table 197. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026) & (US$ Million) Table 201. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (US$ Million) & (2027-2032) Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Percutaneous Coronary Intervention (PCI) Treatment Instruments Image Figure 2. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Share 2021 VS 2025 VS 2032 Figure 4. Coronary Pathway Assistive Instruments Image Figure 5. Interventional Treatment Instruments Image Figure 6. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size (US$ Million) & (2021-2032) Figure 12. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2021-2032) Figure 19. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2021-2032) Figure 22. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032) Figure 24. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032) Figure 25. North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Country (2021-2032) Figure 26. United States Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032) Figure 31. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032) Figure 32. Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Country (2021-2032) Figure 33. Germany Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032) Figure 43. China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032) Figure 44. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032) Figure 46. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032) Figure 47. Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Region (2021-2032) Figure 48. Japan Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032) Figure 56. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032) Figure 57. SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Country (2021-2032) Figure 58. Brazil Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Coronary Pathway Assistive Instruments
  • Interventional Treatment Instruments
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Medtronic
  • OrbusNeich Medical Company
  • MicroPort Scientific Corporation
  • Suzhou Innomed Medical Device
  • Shunmei Medical
  • Shanghai INT Medical Instruments
  • Lepu Medical Technology
  • APT Medical
  • BrosMed Medical
  • Terumo Corporation
  • QualiMe
  • Merit Medical
  • Curatia Medical
  • Cordis
  • Cardionovum
  • Boston Scientific
  • ASAHI INTECC
  • Abbott
  • Zhejiang Barty Medical Technology
  • Shenzhen MicroApproach Medical Technology
  • Beijing Demax Medical Technology
  • JW Medical Systems
  • SINOMED
  • Kinhely Bio-Tech
  • Shandong Huaan Biotechnology
  • Blue Sail Medical
  • Shanghai Bio-heart Biological Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Type
  3. 1.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Coronary Pathway Assistive Instruments
  5. 1.2.3 Interventional Treatment Instruments
  6. 1.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market by Application
  7. 1.3.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Dynamics
  1. 2.1 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Trends
  2. 2.2 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Drivers
  3. 2.3 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Opportunities and Challenges
  4. 2.4 Percutaneous Coronary Intervention (PCI) Treatment Instruments Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Perspective (2021-2032)
  2. 3.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Growth Trends by Region
  3. 3.2.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2021-2026)
  5. 3.2.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Players
  2. 4.1.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Players (2021-2026)
  3. 4.1.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Key Players Headquarters & Area Served
  7. 4.4 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players, Product Type & Application
  8. 4.5 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Market CR5 and HHI
  11. 4.6.3 2025 Percutaneous Coronary Intervention (PCI) Treatment Instruments Tier 1, Tier 2, and Tier 3
5 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Type
  1. 5.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 5.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Type (2021-2032)
6 Percutaneous Coronary Intervention (PCI) Treatment Instruments Market Size by Application
  1. 6.1 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  3. 6.3 Global Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 OrbusNeich Medical Company
  8. 7.2.1 OrbusNeich Medical Company Company Information
  9. 7.2.2 OrbusNeich Medical Company Business Overview
  10. 7.2.3 OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  11. 7.2.4 OrbusNeich Medical Company Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  12. 7.2.5 OrbusNeich Medical Company Recent Developments
  13. 7.3 MicroPort Scientific Corporation
  14. 7.3.1 MicroPort Scientific Corporation Company Information
  15. 7.3.2 MicroPort Scientific Corporation Business Overview
  16. 7.3.3 MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MicroPort Scientific Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  18. 7.3.5 MicroPort Scientific Corporation Recent Developments
  19. 7.4 Suzhou Innomed Medical Device
  20. 7.4.1 Suzhou Innomed Medical Device Company Information
  21. 7.4.2 Suzhou Innomed Medical Device Business Overview
  22. 7.4.3 Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Suzhou Innomed Medical Device Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  24. 7.4.5 Suzhou Innomed Medical Device Recent Developments
  25. 7.5 Shunmei Medical
  26. 7.5.1 Shunmei Medical Company Information
  27. 7.5.2 Shunmei Medical Business Overview
  28. 7.5.3 Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Shunmei Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  30. 7.5.5 Shunmei Medical Recent Developments
  31. 7.6 Shanghai INT Medical Instruments
  32. 7.6.1 Shanghai INT Medical Instruments Company Information
  33. 7.6.2 Shanghai INT Medical Instruments Business Overview
  34. 7.6.3 Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai INT Medical Instruments Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  36. 7.6.5 Shanghai INT Medical Instruments Recent Developments
  37. 7.7 Lepu Medical Technology
  38. 7.7.1 Lepu Medical Technology Company Information
  39. 7.7.2 Lepu Medical Technology Business Overview
  40. 7.7.3 Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Lepu Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  42. 7.7.5 Lepu Medical Technology Recent Developments
  43. 7.8 APT Medical
  44. 7.8.1 APT Medical Company Information
  45. 7.8.2 APT Medical Business Overview
  46. 7.8.3 APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  47. 7.8.4 APT Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  48. 7.8.5 APT Medical Recent Developments
  49. 7.9 BrosMed Medical
  50. 7.9.1 BrosMed Medical Company Information
  51. 7.9.2 BrosMed Medical Business Overview
  52. 7.9.3 BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BrosMed Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  54. 7.9.5 BrosMed Medical Recent Developments
  55. 7.10 Terumo Corporation
  56. 7.10.1 Terumo Corporation Company Information
  57. 7.10.2 Terumo Corporation Business Overview
  58. 7.10.3 Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Terumo Corporation Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  60. 7.10.5 Terumo Corporation Recent Developments
  61. 7.11 QualiMe
  62. 7.11.1 QualiMe Company Information
  63. 7.11.2 QualiMe Business Overview
  64. 7.11.3 QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  65. 7.11.4 QualiMe Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  66. 7.11.5 QualiMe Recent Developments
  67. 7.12 Merit Medical
  68. 7.12.1 Merit Medical Company Information
  69. 7.12.2 Merit Medical Business Overview
  70. 7.12.3 Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Merit Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  72. 7.12.5 Merit Medical Recent Developments
  73. 7.13 Curatia Medical
  74. 7.13.1 Curatia Medical Company Information
  75. 7.13.2 Curatia Medical Business Overview
  76. 7.13.3 Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Curatia Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  78. 7.13.5 Curatia Medical Recent Developments
  79. 7.14 Cordis
  80. 7.14.1 Cordis Company Information
  81. 7.14.2 Cordis Business Overview
  82. 7.14.3 Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Cordis Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  84. 7.14.5 Cordis Recent Developments
  85. 7.15 Cardionovum
  86. 7.15.1 Cardionovum Company Information
  87. 7.15.2 Cardionovum Business Overview
  88. 7.15.3 Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Cardionovum Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  90. 7.15.5 Cardionovum Recent Developments
  91. 7.16 Boston Scientific
  92. 7.16.1 Boston Scientific Company Information
  93. 7.16.2 Boston Scientific Business Overview
  94. 7.16.3 Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Boston Scientific Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  96. 7.16.5 Boston Scientific Recent Developments
  97. 7.17 ASAHI INTECC
  98. 7.17.1 ASAHI INTECC Company Information
  99. 7.17.2 ASAHI INTECC Business Overview
  100. 7.17.3 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  101. 7.17.4 ASAHI INTECC Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  102. 7.17.5 ASAHI INTECC Recent Developments
  103. 7.18 Abbott
  104. 7.18.1 Abbott Company Information
  105. 7.18.2 Abbott Business Overview
  106. 7.18.3 Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Abbott Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  108. 7.18.5 Abbott Recent Developments
  109. 7.19 Zhejiang Barty Medical Technology
  110. 7.19.1 Zhejiang Barty Medical Technology Company Information
  111. 7.19.2 Zhejiang Barty Medical Technology Business Overview
  112. 7.19.3 Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Zhejiang Barty Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  114. 7.19.5 Zhejiang Barty Medical Technology Recent Developments
  115. 7.20 Shenzhen MicroApproach Medical Technology
  116. 7.20.1 Shenzhen MicroApproach Medical Technology Company Information
  117. 7.20.2 Shenzhen MicroApproach Medical Technology Business Overview
  118. 7.20.3 Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Shenzhen MicroApproach Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  120. 7.20.5 Shenzhen MicroApproach Medical Technology Recent Developments
  121. 7.21 Beijing Demax Medical Technology
  122. 7.21.1 Beijing Demax Medical Technology Company Information
  123. 7.21.2 Beijing Demax Medical Technology Business Overview
  124. 7.21.3 Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Beijing Demax Medical Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  126. 7.21.5 Beijing Demax Medical Technology Recent Developments
  127. 7.22 JW Medical Systems
  128. 7.22.1 JW Medical Systems Company Information
  129. 7.22.2 JW Medical Systems Business Overview
  130. 7.22.3 JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  131. 7.22.4 JW Medical Systems Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  132. 7.22.5 JW Medical Systems Recent Developments
  133. 7.23 SINOMED
  134. 7.23.1 SINOMED Company Information
  135. 7.23.2 SINOMED Business Overview
  136. 7.23.3 SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  137. 7.23.4 SINOMED Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  138. 7.23.5 SINOMED Recent Developments
  139. 7.24 Kinhely Bio-Tech
  140. 7.24.1 Kinhely Bio-Tech Company Information
  141. 7.24.2 Kinhely Bio-Tech Business Overview
  142. 7.24.3 Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  143. 7.24.4 Kinhely Bio-Tech Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  144. 7.24.5 Kinhely Bio-Tech Recent Developments
  145. 7.25 Shandong Huaan Biotechnology
  146. 7.25.1 Shandong Huaan Biotechnology Company Information
  147. 7.25.2 Shandong Huaan Biotechnology Business Overview
  148. 7.25.3 Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Shandong Huaan Biotechnology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  150. 7.25.5 Shandong Huaan Biotechnology Recent Developments
  151. 7.26 Blue Sail Medical
  152. 7.26.1 Blue Sail Medical Company Information
  153. 7.26.2 Blue Sail Medical Business Overview
  154. 7.26.3 Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Blue Sail Medical Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  156. 7.26.5 Blue Sail Medical Recent Developments
  157. 7.27 Shanghai Bio-heart Biological Technology
  158. 7.27.1 Shanghai Bio-heart Biological Technology Company Information
  159. 7.27.2 Shanghai Bio-heart Biological Technology Business Overview
  160. 7.27.3 Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Shanghai Bio-heart Biological Technology Percutaneous Coronary Intervention (PCI) Treatment Instruments Product Portfolio
  162. 7.27.5 Shanghai Bio-heart Biological Technology Recent Developments
8 North America
  1. 8.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2021-2032)
  2. 8.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 8.2.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026)
  4. 8.2.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032)
  5. 8.3 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032)
  6. 8.4 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  7. 8.4.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026)
  8. 8.4.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032)
  9. 8.5 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032)
  10. 8.6 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country
  11. 8.6.1 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026)
  13. 8.6.3 North America Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2021-2032)
  2. 9.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 9.2.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026)
  4. 9.2.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032)
  5. 9.3 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032)
  6. 9.4 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  7. 9.4.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026)
  8. 9.4.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032)
  9. 9.5 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032)
  10. 9.6 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country
  11. 9.6.1 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026)
  13. 9.6.3 Europe Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2021-2032)
  2. 10.2 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 10.2.1 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026)
  4. 10.2.2 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032)
  5. 10.3 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032)
  6. 10.4 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  7. 10.4.1 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026)
  8. 10.4.2 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032)
  9. 10.5 China Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2021-2032)
  2. 11.2 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 11.2.1 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026)
  4. 11.2.2 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032)
  5. 11.3 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032)
  6. 11.4 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  7. 11.4.1 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026)
  8. 11.4.2 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032)
  9. 11.5 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032)
  10. 11.6 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country
  11. 11.6.1 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026)
  13. 11.6.3 Asia Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue (2021-2032)
  2. 12.2 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Type (2027-2032)
  5. 12.3 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Application (2027-2032)
  9. 12.5 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country
  11. 12.6.1 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Percutaneous Coronary Intervention (PCI) Treatment Instruments Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst